Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals pre-existing immunity as a predictor of therapy outcomes


ABSTRACT: Oncolytic adenovirus Ad5/3-E2F-d24-hTNFa-IRES-hIL2 (TILT-123, igrelimogene litadenorepvec) shows promise as a therapeutic agent capable of causing tumor regression and activating host immunity. A phase 1 clinical study TUNIMO (NCT04695327) assessed its safety as monotherapy in patients with various solid tumors. Through single-cell profiling of peripheral blood, we identified distinct immunological features distinguishing responders from non-responders. Specifically, at baseline, responders demonstrated enhanced cytotoxic markers and stronger immune cell communication networks. Moreover, higher baseline CD16+ monocytes correlated with improved survival, while elevated regulatory T cells predicted poor response. T and B cell evaluation revealed contrasting patterns: higher specific T cells in responders, while elevated memory B cells predicted poor survival. Both cell types showed receptor segments previously associated with other viral responses. These findings emphasize that comprehensive biomarker analysis of peripheral blood should include not only cell frequencies but also transcriptional changes and distinct patterns of cellular and humoral immunity.

INSTRUMENT(S): Illumina NovaSeq X

ORGANISM(S): Homo sapiens

SUBMITTER: Tatiana Kudling 

PROVIDER: E-MTAB-14799 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2024-12-09 | E-MTAB-14191 | biostudies-arrayexpress
2023-07-24 | E-MTAB-12407 | biostudies-arrayexpress
2023-02-17 | E-MTAB-12642 | biostudies-arrayexpress
2024-12-09 | E-MTAB-14169 | biostudies-arrayexpress
2023-02-28 | E-MTAB-12524 | biostudies-arrayexpress
2023-05-31 | E-MTAB-12784 | biostudies-arrayexpress
2024-02-27 | E-MTAB-13581 | biostudies-arrayexpress
2024-04-23 | E-MTAB-14010 | biostudies-arrayexpress
2022-05-02 | E-MTAB-10430 | biostudies-arrayexpress
2021-03-17 | E-MTAB-10026 | biostudies-arrayexpress